drugset / Trial / NCT02376465

A Pilot Evaluation of an Experimental BLI4600 Formulation for Bowel Preparation in Adult Patients Undergoing Colonoscopy

NCT02376465 ↗

Phase 2 Completed 45 enrolled Braintree Laboratories
Non-randomizedParallel-groupOpen-labelPrevention

Summary

To evaluate the safety, tolerance and efficacy of BLI4600 in multiple dosing regimens as a bowel preparation prior to colonoscopy in adult patients.

Timeline

Start
2015-01
Primary completion
2015-06
Completion
2015-06

Drugs

EvaluationDrugModalityDoseRoute
Subject BLI4600 Unknown — Oral

Indications

No indication recorded.